H.R. 2416 · 114th Congress
To amend the Federal Food, Drug, and Cosmetic Act to evaluate the potential use of evidence from clinical experience to help support the approval of new indications for approved drugs, and for other purposes.
- Stage
- In committee
- Sponsor
- Michael Burgess
- Introduced
- 2015-05-19
- Latest action
- 2015-05-22 · Referred to the Subcommittee on Health.
Votes
No linked votes are available for this bill.